Cervical Ripening with Misoprostol in Postmenopausal Women
Author Information
Author(s): K.S. Oppegaard, M. Lieng, A. Berg, O. Istre, E. Qvigstad, B.I. Nesheim
Primary Institution: Ullevål University Hospital
Hypothesis
There is no clinically significant difference in preoperative baseline cervical dilatation between postmenopausal women who receive vaginal misoprostol and those who receive vaginal placebo after pre-treatment with estradiol.
Conclusion
The study aims to determine if misoprostol is effective for cervical ripening in postmenopausal women after estradiol treatment.
Supporting Evidence
- The study is designed to compare the effects of misoprostol and placebo on cervical ripening.
- Previous studies have shown mixed results regarding the effectiveness of misoprostol in cervical ripening.
Takeaway
This study is trying to find out if a medicine called misoprostol can help make it easier for older women to have a procedure on their uterus.
Methodology
The study is a randomised double-blind placebo-controlled trial comparing misoprostol and placebo in postmenopausal women prior to hysteroscopy.
Potential Biases
Potential bias in self-reporting of outcomes and acceptability.
Limitations
The study may have limitations related to the sample size and the specific population of postmenopausal women.
Participant Demographics
Postmenopausal women referred for day-care operative hysteroscopy.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website